The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug

The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug

by Barry Werth
     
 

View All Available Formats & Editions

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing — atom by atom —

Overview

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing — atom by atom — both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Editorial Reviews

From the Publisher
Geoffrey Smith Business Week A riveting tale that has more in common with a John Grisham thriller than with tomes on modern science.

John Schwartz The Washington Post The inside skinny...a high stakes tale of adventure and intrigue: Barbarians at the Lab. Werth's work is a gem.

John Travis The Boston Globe Fascinating...gripping...must reading for anyone curious about an industry that promises to revolutionize medical care in the next century.

Publishers Weekly - Publisher's Weekly
A startup pharmaceutical company is the focus of this intriguing look at the nexus of biotechnology and high finance; features a new epilogue by the author. (Mar.)

Product Details

ISBN-13:
9780671510572
Publisher:
Simon & Schuster
Publication date:
03/01/1995
Edition description:
REV
Pages:
464
Sales rank:
228,547
Product dimensions:
5.50(w) x 8.44(h) x 1.10(d)

Meet the Author

Barry Werth is an award-winning journalist whose articles have appeared in such publications as The New York Times, Washington Monthly, and GQ, where he is a writer-at-large. Currently at work on an expose about doctors and lawyers, he lives in Northampton, Massachusetts.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >